Case report reveals radiologic improvement in invasive pulmonary aspergillosis via targeted antifungal therapy in a pediatric AML patient, suggesting optimized treatment strategies.
Therapeutic response in refractory invasive pulmonary aspergillosis may depend not only on antifungal class escalation, but also on formulation choice. In this complex pediatric acute myeloid leukemia (AML) case, radiologic improvement followed combination therapy and switch to brand‐name liposomal amphotericin B, underscoring the importance of individualized antifungal optimization.
No takes yet. Share an insight, caveat, or question.
Khamis et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: